It acts on three metabolic receptors simultaneously GLP-1, GIP, and glucagon through a single molecule
Side effects may become more noticeable after dose increases
With regular monitoring and expert guidance, youll be able to achieve and sustain your weight loss results in a safe, effective, and supportive environment
(this is why SIPs are usually the best way to invest)
Dual GLP-1/GIP agonist tirzepatide has exhibited impressive histological benefits including both MASH resolution and fibrosis improvement rates exceeding 50% in phase 2 studies
Pharmacists play a central role in monitoring, counseling on, and facilitating access to GLP-1 RAs, thereby supporting optimal clinical outcomes and therapy tolerability